Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism MYLPF inhibitors(myosin light chain, phosphorylatable, fast skeletal muscle inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cerebral Palsy | Preclinical | US | - | |
Movement Disorders | Preclinical | US | - | |
Multiple Sclerosis | Preclinical | US | - | |
Muscle Hypertonia | Preclinical | US | - | |
Muscular Dystrophy, Duchenne | Preclinical | US | - | |
Stroke | Preclinical | US | - |